Current Study: O 9

Study: O 9

Investigator: Thomas Marbury, MD
Category:
Research Study: Liver Studies

Purpose:
• To determine how the investigational drug is broken down and removed from the body in female volunteers with liver impairment when compared to volunteers with normal liver function
• Information regarding safety and side effects that may occur will also be collected
• This study is for research purposes only and is not intended to treat your liver disease

Method of Administration:
Single oral dose of study drug, given as 2 tablets

Investigator:
Thomas Marbury, MD

To qualify:
• Female
• 18 to 75 years old
• Must have decreased liver function or disease such as fatty liver disease (NASH), Hepatitis C, past history of alcohol related liver disease or cirrhosis
• Volunteers may be taking medicines such as spironolactone (Aldactone®), furosemide (Lasix®), lactulose, or rifaximin (Xifaxan®)
• May also have ascites (fluid in your abdomen) or encephalopathy (brain condition that causes irritability or trouble sleeping)

Length/Duration:
• 1 eligibility screening visit
• 7 days and 6 nights in our research facility
• 1 end of study follow-up visit

Compensation:
Qualified female participants will be compensated up to $1,825 for time and travel
Qualified female participants will receive study medication, study related physical exams

Location:
5055 South Orange Avenue, Orlando, FL 32809

Orlando Clinical Research Center
5055 South Orange Avenue
Orlando, FL 32809

Recruiting Number: 407.240.7878

Apply now for Study: O 9

Close